pepmg_

Study summary · research use only

FOXO4-SP6 axis controls surface epithelium commitment by mediating epigenomic remodeling

Study · human · Stem cell reports · 2025 · DOI 10.1016/j.stemcr.2025.102445 · PMID 40086444

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study (species not specified) used a KRT8 reporter system to identify FOXO4 and SP6 as regulators of surface epithelium (SE) commitment. The abstract reports that the FOXO4-SP6 axis governs SE fate, and that disrupting it impedes SE fate determination. FOXO4 was reported to shape SE chromatin accessibility and regulate H3K4me3 deposition, while SP6, described as a novel effector of FOXO4, was reported to activate SE-specific genes by modulating H3K27ac deposition across super-enhancers. The authors describe the FOXO4-SP6 axis as relevant to understanding SE fate decisions and to research into ectodermal dysplasia.

Abstract

Proper development of surface epithelium (SE) is a requisite for the normal development and function of ectodermal appendages; however, the molecular mechanisms underlying SE commitment remain largely unexplored. Here, we developed a KRT8 reporter system and utilized it to identify FOXO4 and SP6 as novel, essential regulators governing SE commitment. We found that the FOXO4-SP6 axis governs SE fate and its abrogation markedly impedes SE fate determination. Mechanistically, FOXO4 regulates SE initiation by shaping the SE chromatin accessibility landscape and regulating the deposition of H3K4me3. SP6, as a novel effector of FOXO4, activates SE-specific genes through modulating the H3K27ac deposition across their super-enhancers. Our work highlights the regulatory function of the FOXO4-SP6 axis in SE development, contributing to an improved understanding of SE fate decisions and providing a research foundation for the therapeutic application of ectodermal dysplasia.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.